• mail us help@statsmarketresearch.com
  • Int'l (+1)-646-781-7170

TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Pharma and Health Care Market - Global Outlook and Forecast 2021-2027

Pharma and Health Care Market - Global Outlook and Forecast 2021-2027

  • Category:Life Sciences
  • Published on : 26 August 2021
  • Pages :112
  • Formats:
  • Report Code:SMR-6554617
Click for best price

Best Price: $2600

This report contains market size and forecasts of Pharma and Health Care in Global, including the following market information:
Global Pharma and Health Care Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Pharma and Health Care market was valued at 1233670 million in 2020 and is projected to reach US$ 1433700 million by 2027, at a CAGR of 3.8% during the forecast period.
We Surveyed the Pharma and Health Care companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pharma and Health Care Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Pharma and Health Care Market Segment Percentages, By Type, 2020 (%)
Bottle
Blister
Others

China Pharma and Health Care Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Pharma and Health Care Market Segment Percentages, By Application, 2020 (%)
OTC Drugs
Prescription Drugs

Global Pharma and Health Care Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Pharma and Health Care Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Total Pharma and Health Care Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Pharma and Health Care Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
Johnson & Johnson
Novartis
Roche
AbbVie
Merck & Co.
Bristol Myers Squibb
GlaxoSmithKline
Pfizer
Sanofi
Takeda
AstraZeneca
Bayer
Eli Lilly & Co.
Gilead Sciences
Amgen
Novo Nordisk
Teva
Boehringer Ingelheim
Biogen
Astellas

TABLE OF CONTENTS

1 Introduction to Research & Analysis Reports
1.1 Pharma and Health Care Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Pharma and Health Care Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Pharma and Health Care Overall Market Size
2.1 Global Pharma and Health Care Market Size: 2021 VS 2027
2.2 Global Pharma and Health Care Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Pharma and Health Care Players in Global Market
3.2 Top Global Pharma and Health Care Companies Ranked by Revenue
3.3 Global Pharma and Health Care Revenue by Companies
3.4 Top 3 and Top 5 Pharma and Health Care Companies in Global Market, by Revenue in 2020
3.5 Global Companies Pharma and Health Care Product Type
3.6 Tier 1, Tier 2 and Tier 3 Pharma and Health Care Players in Global Market
3.6.1 List of Global Tier 1 Pharma and Health Care Companies
3.6.2 List of Global Tier 2 and Tier 3 Pharma and Health Care Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Pharma and Health Care Market Size Markets, 2021 & 2027
4.1.2 Bottle
4.1.3 Blister
4.1.4 Others
4.2 By Type - Global Pharma and Health Care Revenue & Forecasts
4.2.1 By Type - Global Pharma and Health Care Revenue, 2016-2021
4.2.2 By Type - Global Pharma and Health Care Revenue, 2022-2027
4.2.3 By Type - Global Pharma and Health Care Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Pharma and Health Care Market Size, 2021 & 2027
5.1.2 OTC Drugs
5.1.3 Prescription Drugs
5.2 By Application - Global Pharma and Health Care Revenue & Forecasts
5.2.1 By Application - Global Pharma and Health Care Revenue, 2016-2021
5.2.2 By Application - Global Pharma and Health Care Revenue, 2022-2027
5.2.3 By Application - Global Pharma and Health Care Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Pharma and Health Care Market Size, 2021 & 2027
6.2 By Region - Global Pharma and Health Care Revenue & Forecasts
6.2.1 By Region - Global Pharma and Health Care Revenue, 2016-2021
6.2.2 By Region - Global Pharma and Health Care Revenue, 2022-2027
6.2.3 By Region - Global Pharma and Health Care Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Pharma and Health Care Revenue, 2016-2027
6.3.2 US Pharma and Health Care Market Size, 2016-2027
6.3.3 Canada Pharma and Health Care Market Size, 2016-2027
6.3.4 Mexico Pharma and Health Care Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Pharma and Health Care Revenue, 2016-2027
6.4.2 Germany Pharma and Health Care Market Size, 2016-2027
6.4.3 France Pharma and Health Care Market Size, 2016-2027
6.4.4 U.K. Pharma and Health Care Market Size, 2016-2027
6.4.5 Italy Pharma and Health Care Market Size, 2016-2027
6.4.6 Russia Pharma and Health Care Market Size, 2016-2027
6.4.7 Nordic Countries Pharma and Health Care Market Size, 2016-2027
6.4.8 Benelux Pharma and Health Care Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Pharma and Health Care Revenue, 2016-2027
6.5.2 China Pharma and Health Care Market Size, 2016-2027
6.5.3 Japan Pharma and Health Care Market Size, 2016-2027
6.5.4 South Korea Pharma and Health Care Market Size, 2016-2027
6.5.5 Southeast Asia Pharma and Health Care Market Size, 2016-2027
6.5.6 India Pharma and Health Care Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Pharma and Health Care Revenue, 2016-2027
6.6.2 Brazil Pharma and Health Care Market Size, 2016-2027
6.6.3 Argentina Pharma and Health Care Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Pharma and Health Care Revenue, 2016-2027
6.7.2 Turkey Pharma and Health Care Market Size, 2016-2027
6.7.3 Israel Pharma and Health Care Market Size, 2016-2027
6.7.4 Saudi Arabia Pharma and Health Care Market Size, 2016-2027
6.7.5 UAE Pharma and Health Care Market Size, 2016-2027
7 Players Profiles
7.1 Johnson & Johnson
7.1.1 Johnson & Johnson Corporate Summary
7.1.2 Johnson & Johnson Business Overview
7.1.3 Johnson & Johnson Pharma and Health Care Major Product Offerings
7.1.4 Johnson & Johnson Pharma and Health Care Revenue in Global (2016-2021)
7.1.5 Johnson & Johnson Key News
7.2 Novartis
7.2.1 Novartis Corporate Summary
7.2.2 Novartis Business Overview
7.2.3 Novartis Pharma and Health Care Major Product Offerings
7.2.4 Novartis Pharma and Health Care Revenue in Global (2016-2021)
7.2.5 Novartis Key News
7.3 Roche
7.3.1 Roche Corporate Summary
7.3.2 Roche Business Overview
7.3.3 Roche Pharma and Health Care Major Product Offerings
7.3.4 Roche Pharma and Health Care Revenue in Global (2016-2021)
7.3.5 Roche Key News
7.4 AbbVie
7.4.1 AbbVie Corporate Summary
7.4.2 AbbVie Business Overview
7.4.3 AbbVie Pharma and Health Care Major Product Offerings
7.4.4 AbbVie Pharma and Health Care Revenue in Global (2016-2021)
7.4.5 AbbVie Key News
7.5 Merck & Co.
7.5.1 Merck & Co. Corporate Summary
7.5.2 Merck & Co. Business Overview
7.5.3 Merck & Co. Pharma and Health Care Major Product Offerings
7.5.4 Merck & Co. Pharma and Health Care Revenue in Global (2016-2021)
7.5.5 Merck & Co. Key News
7.6 Bristol Myers Squibb
7.6.1 Bristol Myers Squibb Corporate Summary
7.6.2 Bristol Myers Squibb Business Overview
7.6.3 Bristol Myers Squibb Pharma and Health Care Major Product Offerings
7.6.4 Bristol Myers Squibb Pharma and Health Care Revenue in Global (2016-2021)
7.6.5 Bristol Myers Squibb Key News
7.7 GlaxoSmithKline
7.7.1 GlaxoSmithKline Corporate Summary
7.7.2 GlaxoSmithKline Business Overview
7.7.3 GlaxoSmithKline Pharma and Health Care Major Product Offerings
7.4.4 GlaxoSmithKline Pharma and Health Care Revenue in Global (2016-2021)
7.7.5 GlaxoSmithKline Key News
7.8 Pfizer
7.8.1 Pfizer Corporate Summary
7.8.2 Pfizer Business Overview
7.8.3 Pfizer Pharma and Health Care Major Product Offerings
7.8.4 Pfizer Pharma and Health Care Revenue in Global (2016-2021)
7.8.5 Pfizer Key News
7.9 Sanofi
7.9.1 Sanofi Corporate Summary
7.9.2 Sanofi Business Overview
7.9.3 Sanofi Pharma and Health Care Major Product Offerings
7.9.4 Sanofi Pharma and Health Care Revenue in Global (2016-2021)
7.9.5 Sanofi Key News
7.10 Takeda
7.10.1 Takeda Corporate Summary
7.10.2 Takeda Business Overview
7.10.3 Takeda Pharma and Health Care Major Product Offerings
7.10.4 Takeda Pharma and Health Care Revenue in Global (2016-2021)
7.10.5 Takeda Key News
7.11 AstraZeneca
7.11.1 AstraZeneca Corporate Summary
7.11.2 AstraZeneca Business Overview
7.11.3 AstraZeneca Pharma and Health Care Major Product Offerings
7.11.4 AstraZeneca Pharma and Health Care Revenue in Global (2016-2021)
7.11.5 AstraZeneca Key News
7.12 Bayer
7.12.1 Bayer Corporate Summary
7.12.2 Bayer Business Overview
7.12.3 Bayer Pharma and Health Care Major Product Offerings
7.12.4 Bayer Pharma and Health Care Revenue in Global (2016-2021)
7.12.5 Bayer Key News
7.13 Eli Lilly & Co.
7.13.1 Eli Lilly & Co. Corporate Summary
7.13.2 Eli Lilly & Co. Business Overview
7.13.3 Eli Lilly & Co. Pharma and Health Care Major Product Offerings
7.13.4 Eli Lilly & Co. Pharma and Health Care Revenue in Global (2016-2021)
7.13.5 Eli Lilly & Co. Key News
7.14 Gilead Sciences
7.14.1 Gilead Sciences Corporate Summary
7.14.2 Gilead Sciences Business Overview
7.14.3 Gilead Sciences Pharma and Health Care Major Product Offerings
7.14.4 Gilead Sciences Pharma and Health Care Revenue in Global (2016-2021)
7.14.5 Gilead Sciences Key News
7.15 Amgen
7.15.1 Amgen Corporate Summary
7.15.2 Amgen Business Overview
7.15.3 Amgen Pharma and Health Care Major Product Offerings
7.15.4 Amgen Pharma and Health Care Revenue in Global (2016-2021)
7.15.5 Amgen Key News
7.16 Novo Nordisk
7.16.1 Novo Nordisk Corporate Summary
7.16.2 Novo Nordisk Business Overview
7.16.3 Novo Nordisk Pharma and Health Care Major Product Offerings
7.16.4 Novo Nordisk Pharma and Health Care Revenue in Global (2016-2021)
7.16.5 Novo Nordisk Key News
7.17 Teva
7.17.1 Teva Corporate Summary
7.17.2 Teva Business Overview
7.17.3 Teva Pharma and Health Care Major Product Offerings
7.17.4 Teva Pharma and Health Care Revenue in Global (2016-2021)
7.17.5 Teva Key News
7.18 Boehringer Ingelheim
7.18.1 Boehringer Ingelheim Corporate Summary
7.18.2 Boehringer Ingelheim Business Overview
7.18.3 Boehringer Ingelheim Pharma and Health Care Major Product Offerings
7.18.4 Boehringer Ingelheim Pharma and Health Care Revenue in Global (2016-2021)
7.18.5 Boehringer Ingelheim Key News
7.19 Biogen
7.19.1 Biogen Corporate Summary
7.19.2 Biogen Business Overview
7.19.3 Biogen Pharma and Health Care Major Product Offerings
7.19.4 Biogen Pharma and Health Care Revenue in Global (2016-2021)
7.19.5 Biogen Key News
7.20 Astellas
7.20.1 Astellas Corporate Summary
7.20.2 Astellas Business Overview
7.20.3 Astellas Pharma and Health Care Major Product Offerings
7.20.4 Astellas Pharma and Health Care Revenue in Global (2016-2021)
7.20.5 Astellas Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

LIST OF TABLES & FIGURES

List of Tables
Table 1. Pharma and Health Care Market Opportunities & Trends in Global Market
Table 2. Pharma and Health Care Market Drivers in Global Market
Table 3. Pharma and Health Care Market Restraints in Global Market
Table 4. Key Players of Pharma and Health Care in Global Market
Table 5. Top Pharma and Health Care Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Pharma and Health Care Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Pharma and Health Care Revenue Share by Companies, 2016-2021
Table 8. Global Companies Pharma and Health Care Product Type
Table 9. List of Global Tier 1 Pharma and Health Care Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Pharma and Health Care Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type ? Global Pharma and Health Care Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Pharma and Health Care Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Pharma and Health Care Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application ? Global Pharma and Health Care Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Pharma and Health Care Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Pharma and Health Care Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region ? Global Pharma and Health Care Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Pharma and Health Care Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Pharma and Health Care Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Pharma and Health Care Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Pharma and Health Care Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Pharma and Health Care Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Pharma and Health Care Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Pharma and Health Care Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Pharma and Health Care Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Pharma and Health Care Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Pharma and Health Care Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Pharma and Health Care Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Pharma and Health Care Revenue, (US$, Mn), 2022-2027
Table 30. Johnson & Johnson Corporate Summary
Table 31. Johnson & Johnson Pharma and Health Care Product Offerings
Table 32. Johnson & Johnson Pharma and Health Care Revenue (US$, Mn), (2016-2021)
Table 33. Novartis Corporate Summary
Table 34. Novartis Pharma and Health Care Product Offerings
Table 35. Novartis Pharma and Health Care Revenue (US$, Mn), (2016-2021)
Table 36. Roche Corporate Summary
Table 37. Roche Pharma and Health Care Product Offerings
Table 38. Roche Pharma and Health Care Revenue (US$, Mn), (2016-2021)
Table 39. AbbVie Corporate Summary
Table 40. AbbVie Pharma and Health Care Product Offerings
Table 41. AbbVie Pharma and Health Care Revenue (US$, Mn), (2016-2021)
Table 42. Merck & Co. Corporate Summary
Table 43. Merck & Co. Pharma and Health Care Product Offerings
Table 44. Merck & Co. Pharma and Health Care Revenue (US$, Mn), (2016-2021)
Table 45. Bristol Myers Squibb Corporate Summary
Table 46. Bristol Myers Squibb Pharma and Health Care Product Offerings
Table 47. Bristol Myers Squibb Pharma and Health Care Revenue (US$, Mn), (2016-2021)
Table 48. GlaxoSmithKline Corporate Summary
Table 49. GlaxoSmithKline Pharma and Health Care Product Offerings
Table 50. GlaxoSmithKline Pharma and Health Care Revenue (US$, Mn), (2016-2021)
Table 51. Pfizer Corporate Summary
Table 52. Pfizer Pharma and Health Care Product Offerings
Table 53. Pfizer Pharma and Health Care Revenue (US$, Mn), (2016-2021)
Table 54. Sanofi Corporate Summary
Table 55. Sanofi Pharma and Health Care Product Offerings
Table 56. Sanofi Pharma and Health Care Revenue (US$, Mn), (2016-2021)
Table 57. Takeda Corporate Summary
Table 58. Takeda Pharma and Health Care Product Offerings
Table 59. Takeda Pharma and Health Care Revenue (US$, Mn), (2016-2021)
Table 60. AstraZeneca Corporate Summary
Table 61. AstraZeneca Pharma and Health Care Product Offerings
Table 62. AstraZeneca Pharma and Health Care Revenue (US$, Mn), (2016-2021)
Table 63. Bayer Corporate Summary
Table 64. Bayer Pharma and Health Care Product Offerings
Table 65. Bayer Pharma and Health Care Revenue (US$, Mn), (2016-2021)
Table 66. Eli Lilly & Co. Corporate Summary
Table 67. Eli Lilly & Co. Pharma and Health Care Product Offerings
Table 68. Eli Lilly & Co. Pharma and Health Care Revenue (US$, Mn), (2016-2021)
Table 69. Gilead Sciences Corporate Summary
Table 70. Gilead Sciences Pharma and Health Care Product Offerings
Table 71. Gilead Sciences Pharma and Health Care Revenue (US$, Mn), (2016-2021)
Table 72. Amgen Corporate Summary
Table 73. Amgen Pharma and Health Care Product Offerings
Table 74. Amgen Pharma and Health Care Revenue (US$, Mn), (2016-2021)
Table 75. Novo Nordisk Corporate Summary
Table 76. Novo Nordisk Pharma and Health Care Product Offerings
Table 77. Novo Nordisk Pharma and Health Care Revenue (US$, Mn), (2016-2021)
Table 78. Teva Corporate Summary
Table 79. Teva Pharma and Health Care Product Offerings
Table 80. Teva Pharma and Health Care Revenue (US$, Mn), (2016-2021)
Table 81. Boehringer Ingelheim Corporate Summary
Table 82. Boehringer Ingelheim Pharma and Health Care Product Offerings
Table 83. Boehringer Ingelheim Pharma and Health Care Revenue (US$, Mn), (2016-2021)
Table 84. Biogen Corporate Summary
Table 85. Biogen Pharma and Health Care Product Offerings
Table 86. Biogen Pharma and Health Care Revenue (US$, Mn), (2016-2021)
Table 87. Astellas Corporate Summary
Table 88. Astellas Pharma and Health Care Product Offerings
Table 89. Astellas Pharma and Health Care Revenue (US$, Mn), (2016-2021)
List of Figures
Figure 1. Pharma and Health Care Segment by Type
Figure 2. Pharma and Health Care Segment by Application
Figure 3. Global Pharma and Health Care Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Pharma and Health Care Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Pharma and Health Care Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Pharma and Health Care Revenue in 2020
Figure 8. By Type - Global Pharma and Health Care Revenue Market Share, 2016-2027
Figure 9. By Application - Global Pharma and Health Care Revenue Market Share, 2016-2027
Figure 10. By Region - Global Pharma and Health Care Revenue Market Share, 2016-2027
Figure 11. By Country - North America Pharma and Health Care Revenue Market Share, 2016-2027
Figure 12. US Pharma and Health Care Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Pharma and Health Care Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Pharma and Health Care Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Pharma and Health Care Revenue Market Share, 2016-2027
Figure 16. Germany Pharma and Health Care Revenue, (US$, Mn), 2016-2027
Figure 17. France Pharma and Health Care Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Pharma and Health Care Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Pharma and Health Care Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Pharma and Health Care Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Pharma and Health Care Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Pharma and Health Care Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Pharma and Health Care Revenue Market Share, 2016-2027
Figure 24. China Pharma and Health Care Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Pharma and Health Care Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Pharma and Health Care Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Pharma and Health Care Revenue, (US$, Mn), 2016-2027
Figure 28. India Pharma and Health Care Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Pharma and Health Care Revenue Market Share, 2016-2027
Figure 30. Brazil Pharma and Health Care Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Pharma and Health Care Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Pharma and Health Care Revenue Market Share, 2016-2027
Figure 33. Turkey Pharma and Health Care Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Pharma and Health Care Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Pharma and Health Care Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Pharma and Health Care Revenue, (US$, Mn), 2016-2027
Figure 37. Johnson & Johnson Pharma and Health Care Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Novartis Pharma and Health Care Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Roche Pharma and Health Care Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. AbbVie Pharma and Health Care Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Merck & Co. Pharma and Health Care Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Bristol Myers Squibb Pharma and Health Care Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. GlaxoSmithKline Pharma and Health Care Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Pfizer Pharma and Health Care Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Sanofi Pharma and Health Care Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. Takeda Pharma and Health Care Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 47. AstraZeneca Pharma and Health Care Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 48. Bayer Pharma and Health Care Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 49. Eli Lilly & Co. Pharma and Health Care Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 50. Gilead Sciences Pharma and Health Care Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 51. Amgen Pharma and Health Care Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 52. Novo Nordisk Pharma and Health Care Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 53. Teva Pharma and Health Care Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 54. Boehringer Ingelheim Pharma and Health Care Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 55. Biogen Pharma and Health Care Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 56. Astellas Pharma and Health Care Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

SELECT A FORMAT

USD GBP EURO YEN Single User Price
USD GBP EURO YEN Multi User Price
USD GBP EURO YEN Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount